Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
0.9702
-0.0498 (-4.88%)
At close: Aug 13, 2025, 4:00 PM
0.9734
-0.0092 (-0.94%)
Pre-market: Aug 14, 2025, 8:47 AM EDT

Akari Therapeutics, Employees

As of December 31, 2024, Akari Therapeutics, had 9 total employees, including 8 full-time and 1 part-time employees. The number of employees decreased by 3 or -25.00% compared to the previous year.

Employees
9
Change (1Y)
-3
Growth (1Y)
-25.00%
Revenue / Employee
n/a
Profits / Employee
-$1,992,222
Market Cap
31.64M

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 20249-3-25.00%
Dec 31, 202312-3-20.00%
Dec 31, 202215666.67%
Dec 31, 202190-
Dec 31, 20209-1-10.00%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Related Stocks

Company Name Employees
UnitedHealth Group 400,000
Johnson & Johnson 138,100
Thermo Fisher Scientific 125,000
Abbott Laboratories 114,000
AstraZeneca 92,900
Novo Nordisk 77,349
Novartis AG 75,883
Merck & Co. 75,000
Employee Rankings